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Abstract
Alterations in oxidative metabolism and defects in mitochondrial Ca2þhandling have been implicated in the pathology of
Huntington’s disease (HD), but existing data are contradictory. We investigated the effect of human mHtt fragments on
oxidative metabolism and Ca2þhandling in isolated brain mitochondria and cultured striatal neurons from the R6/2 mouse
model of HD. Non-synaptic and synaptic mitochondria isolated from the brains of R6/2 mice had similar respiratory rates and
Ca2þuptake capacity compared with mitochondria from wild-type (WT) mice. Respiratory activity of cultured striatal neurons
measured with Seahorse XF24 flux analyzer revealed unaltered cellular respiration in neurons derived from R6/2 mice compared
with neurons from WT animals. Consistent with the lack of respiratory dysfunction, ATP content of cultured striatal neurons
from R6/2 and WT mice was similar. Mitochondrial Ca2þaccumulation was also evaluated in cultured striatal neurons from R6/2
and WT animals. Our data obtained with striatal neurons derived from R6/2 and WT mice show that both glutamate-induced in-
creases in cytosolic Ca2þand subsequent carbonilcyanide p-triflouromethoxyphenylhydrazone-induced increases in cytosolic
Ca2þwere similar between WT and R6/2, suggesting that mitochondria in neurons derived from both types of animals accumu-
lated comparable amounts of Ca2þ. Overall, our data argue against respiratory deficiency and impaired Ca2þhandling induced
by human mHtt fragments in both isolated brain mitochondria and cultured striatal neurons from transgenic R6/2 mice.
Huntington’s disease (HD) is an incurable neurodegenerative
disorder characterized by progressively worsening motor, psy-
chiatric, and cognitive maladies (1). In HD, the exon 1 CAG re-
peat stretch of the gene that encodes the huntingtin protein
(Htt) is mutated, resulting in elongation of this domain (2).
Mutant huntingtin (mHtt) possesses an extended polyglutamine
(polyQ) tract that, when expanded in humans beyond 35 gluta-
mines, leads to striatal and cortical degenerations and, subse-
quently, to development of HD symptoms (2). The exact
mechanism by which mHtt exerts its deleterious effects in neu-
rons is not clear, but bioenergetic defects and aberrant mito-
chondrial Ca2þhandling have been implicated as possible
factors contributing to neuronal dysfunction in HD (3,4).
In our previous studies, we investigated the effect of human
full-length mHtt on respiratory activity and Ca2þuptake capac-
ity in brain synaptic and non-synaptic mitochondria as well as
striatal and cortical neurons from transgenic YAC128 mice (5,6).
Despite significant effort, we found no evidence for mHtt-
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induced alterations in respiration and Ca2þuptake capacity of
mitochondria from wild-type (WT) and YAC128 mice. Whether
HD pathogenesis is mediated by full-length mHtt or fragments
of mHtt remains not completely understood. Previous studies
suggested that mHtt fragments might be more toxic than full-
length mHtt (7,8) and it was shown that reduction in mHtt frag-
ment generation improved the phenotype of HD mice (9–11).
Here, we hypothesize that fragments of human mHtt, contrary
to full-length human mHtt, are more deleterious and exert a
detrimental effect on mitochondrial respiration and
Ca2þhandling. Consequently, in the present study, we assessed
the effect of mHtt fragments on mitochondrial respiratory activ-
ity and Ca2þhandling in synaptic and non-synaptic brain mito-
chondria and striatal neurons from the R6/2 mouse model of
HD.
The R6/2 mouse model is one of the first developed and
most well-studied transgenic mouse models of HD (12). These
mice express the N-terminal fragment of human mHtt with a
144-glutamine stretch and display overt behavioral abnormali-
ties by 6 weeks. In this study, symptomatic 6–8-week old R6/2
mice were utilized to probe the effect of mHtt fragments on mi-
tochondrial respiratory function and Ca2þuptake capacity. The
major findings of the present study are that (i) there is no differ-
ence in respiratory rates and Ca2þuptake capacities between
brain mitochondria isolated from R6/2 and WT mice; and (ii)
that primary striatal neurons from R6/2 and WT mice showed
no difference in oxygen consumption rates (OCRs), cellular ATP
levels, and mitochondrial Ca2þaccumulation.
Results
In our experiments, we used the R6/2 mouse model of HD,
which expresses exon 1 of human mHtt (12). These mice exhibit
a behavioral phenotype that manifests by 6 weeks of age as
limb clasping when suspended by the tail (12,13). The presence
of this phenotype is consistent with previous reports describing
this and other mouse models of HD (5,12,14).
To assess the effect of mHtt fragments on mitochondrial res-
piration, we used Percoll gradient-purified brain non-synaptic
(neuronal plus glial) and synaptic (pure neuronal) mitochondria
isolated from 6- to 8-week-old R6/2 and background B6CBA
(WT) mice. Each R6/2 mouse demonstrated clasping behavior
and each animal was genotyped to confirm the presence of the
mutation in the Htt gene (Fig. 1). Previously, it was hypothesized
that bovine serum albumin (BSA) may displace mHtt from the
outer mitochondrial membrane and hence preclude it from ex-
erting deleterious effects on mitochondrial functions (15).
Therefore, although BSA is commonly used during mitochon-
drial isolation and purification to maintain mitochondrial integ-
rity (16), we omitted BSA from all of our experiments involving
isolated mitochondria unless stated otherwise. We assessed mi-
tochondrial respiratory activity in both non-synaptic (Fig. 2) and
synaptic (Fig. 3) mitochondria using either a combination of the
complex I substrates pyruvate (3 mM) and malate (1 mM) or the
complex II substrate succinate (3 mM). In experiments with suc-
cinate, the incubation medium was supplemented with gluta-
mate (3 mM) to remove oxaloacetate by transaminase reaction
and prevent oxaloacetate-mediated inhibition of succinate de-
hydrogenase (17,18). For all experiments, basal respiration of
mitochondria was measured in the presence of substrates only
(V2), followed by ADP-stimulated respiration (V3), controlled res-
piration after ADP-depletion (V4), and, finally, maximal,
uncoupled respiration stimulated by 2,4-dinitrophenol (VDNP).
In these experiments, we found that under all tested conditions
non-synaptic and synaptic mitochondria from R6/2 animals
had similar respiratory rates compared with mitochondria from
WT animals (Figs. 2 and 3).
In line with our data, Yano et al. (19) did not find a difference
in respiratory activity of synaptic and non-synaptic mitochon-
dria from R6/2 mice compared with mitochondria from WT
animals. On the other hand, the authors found evidence for
mHtt-induced inhibition of protein import into mitochondria,
and proposed that such an inhibition might alter mitochondrial
functions at later stages of HD (19). We analyzed expression of
several nuclear-encoded mitochondrial proteins, including a
39 kDa subunit of Complex I, 30 and 70 kDa subunits of Complex
II, aconitase 2, Mn-dependent superoxide dismutase (MnSOD),
cyclophilin D (CyD) and a-subunit of ATP synthase in brain non-
synaptic and synaptic mitochondria isolated from 8-week-old
R6/2 and WT mice. VDAC1, (voltage-dependent anion channel 1
or mitochondrial porin), a protein in the outer mitochondrial
membrane, was used as a loading control. In these experiments,
we did not find any evidence for decreased expression of the an-
alyzed proteins in mitochondria from R6/2 compared with mito-
chondria from WT mice (Fig. 4). These findings argue against
mHtt-induced inhibition of mitochondrial protein import and
its potential role in inhibition of mitochondrial respiration.
Next, we compared the Ca2þuptake capacity in synaptic and
non-synaptic mitochondria isolated from 6- to 8-week-old R6/2
and WT mice. Mitochondria were subjected to 10 mM Ca2þpulses
every 2 min (Figs. 5 and 6). The Ca2þuptake capacities in synap-
tic and non-synaptic mitochondria from R6/2 and WT mice ap-
peared to be similar. In experiments with synaptic
Figure 1. Comparison of motor phenotype of 6-week old R6/2 and WT mice and
representative genotyping. (A) typical posture of a WT mouse following suspen-
sion by the tail with fore- and hind-limbs extended away from the body (B) the
usual feet-clasping posture adopted by an R6/2 mouse within 10 s of suspension
by the tail. (C) representative genotyping data of tail tissue from WT and R6/2
mice. (D) internal positive control.
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mitochondria, Ca2þuptake capacity was lower than in experi-
ments with non-synaptic mitochondria (Fig. 6). To improve
Ca2þuptake capacity in synaptic mitochondria, we used BSA,
which increases Ca2þuptake capacity, as shown in our previous
study (6). In this study, BSA increased Ca2þuptake capacity of
synaptic mitochondria. Importantly, BSA similarly increased
Ca2þuptake capacity in synaptic mitochondria from both R6/2
and WT mice (Fig. 6B and C). Similar results were obtained with
non-synaptic mitochondria (not shown).
Although mitochondria isolated from brains of R6/2 and WT
mice had similar respiratory activities, we could not rule out the
effect of mHtt fragments on mitochondrial respiration under
more physiological conditions. Striatum is the most vulnerable
region of the brain in HD (20). Consequently, we examined the
respiratory activities of cultured striatal neurons derived from
R6/2 and WT mice using the Seahorse XF24 extracellular flux
analyzer. Additionally, in these experiments we evaluated gly-
colytic activities in striatal neurons. OCR was used to evaluate
cellular respiration and extracellular acidification rate (ECAR)
was used to assess glycolytic activity (5). Each experiment fol-
lowed the same protocol with sequential measurements of
basal respiratory activity, oligomycin-sensitive respiration cou-
pled to ATP synthesis, and 2,4-DNP-stimulated, maximal respi-
ration. At the end of the experiment, neurons were treated with
rotenone and antimycin A to completely inhibit mitochondrial
respiration. It was previously suggested that supplementing the
bath solution with 15 mM pyruvate in addition to 10 mM glucose
would accentuate mitochondrial respiration (21). Under these
‘high glucose plus pyruvate’ conditions, we did not find any dif-
ference in respiration and glycolytic activities of striatal neu-
rons from R6/2 and WT mice (Fig. 7A and C).
Recently, it was proposed, that impaired respiratory activity
may become apparent in mHtt-expressing neurons when the cells
are incubated in a ‘low glucose’ medium that contained no pyru-
vate (22). Under these conditions, neurons from BACHD rats had
decreased carbonilcyanide p-triflouromethoxyphenylhydrazone
(FCCP)-stimulated maximal respiratory rates compared with neu-
rons from WT animals. We assessed OCR and ECAR of striatal neu-
rons from R6/2 and WT animals in ‘low glucose’ medium (2.5 mM
glucose, no pyruvate) and did not find any statistically significant
difference in respiratory and glycolytic activities of these cells (Fig.
7B and D). Consistent with the lack of impairment in respiratory
and glycolytic activities in striatal neurons, ATP levels in neurons
from R6/2 mice (17.961.1 nmol ATP/mg protein, N¼ 5) were not
statistically different compared with ATP levels in neurons from
WT mice (18.761.0 nmol ATP/mg protein, N¼ 5).
We also assessed mitochondrial Ca2þaccumulation in stria-
tal neurons derived from R6/2 and WT mice. For these measure-
ments, we stimulated Ca2þ influx into neurons and
subsequently into mitochondria by briefly exposing cells to glu-
tamate (25 mM glutamate plus 10 mM glycine) (Fig. 8). Changes in
cytosolic Ca2þwere monitored by following fluorescence of
A B
C D
Figure 2. Respiratory activity of brain non-synaptic mitochondria isolated from 6- to 8-week-old WT (thin traces) and R6/2 (thick traces) mice. In A and B are represen-
tative traces of mitochondrial O2 consumption for mitochondria at 37 C in incubation medium supplemented with pyruvate (3 mM) plus malate (1 mM) or succinate
(3 mM) plus glutamate (3 mM), respectively. Arrows indicate the addition of either non-synaptic mitochondria (Mtc), 200 mM ADP, or 60 mM 2,4-DNP. In (C) and (D) are
statistical analyses of respiratory rates. Data are presented as mean6SEM from 5 separate experiments. Here and in all other experiments with isolated mitochondria,
three WT and three transgenic R6/2 mice were used in each experiment.
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Fura-2FF. After glutamate removal and return of cytosolic
Ca2þ to near resting level, the release of mitochondrial Ca2þ into
the cytosol was triggered by mitochondrial depolarization with
1 mM FCCP (Fig. 8). The magnitude of cytosolic Ca2þelevation fol-
lowing depolarization was taken as a measure of mitochondrial
Ca2þaccumulation in situ as described previously (6,23). To avoid
Ca2þ influx into cells from the extracellular medium, Ca2þwas
omitted from the bath solution. To prevent Ca2þextrusion from
the cell via the Naþ/Ca2þexchanger during FCCP-induced in-
crease in cytosolic Ca2þ, external Naþwas replaced with equi-
molar N-methyl-D-glucamine (NMDG) during FCCP application
(24). NMDG is a bulk organic cation that cannot be transported
by the Naþ/Ca2þexchanger and, therefore, precludes the extru-
sion of Ca2þvia this mechanism. In these experiments, neurons
from R6/2 and WT mice showed comparable transient increases
in cytosolic Ca2þduring glutamate application (Fig. 8C). The in-
crease in cytosolic Ca2þ triggered by FCCP was also not different
between neurons from R6/2 and WT mice (Fig. 8D). This result,
similar to the results obtained with Ca2þuptake capacity in iso-
lated mitochondria (Figs. 5 and 6), argues against mHtt
fragment-mediated alterations in mitochondrial
Ca2þaccumulation in the R6/2 mouse model of HD.
Nevertheless, we believe that the lack of detectable func-
tional defects does not rule out possible alterations in mito-
chondrial morphology in HD. Previously, morphological
imbalance and a shift toward augmented fission was reported
in mouse and cell models of HD (25–28). In addition, a dramatic
enlargement of mitochondria in neurons (29,30) and peripheral
cells (31,32) expressing mHtt was reported. In our experiments,
we used live-cell laser spinning-disk confocal microscopy and
3D reconstruction of the mitochondrial network in neurons
from WT and R6-2 mice. In parallel experiments, we employed
transmission electron microscopy to substantiate data obtained
with confocal microscopy. In all analyzed striatal neurons from
WT mice (142 neurons), mitochondria had a normal worm-like
appearance whereas in about 24% of neurons from R6/2 mice
(35 out of 148 analyzed neurons) most of mitochondria were
fragmented while some mitochondria were enlarged (Fig. 9).
Yet, despite altered mitochondrial morphology in this subpopu-
lation of neurons, the entire neuronal population from R6/2
mice had similar respiratory activities and Ca2þhandling com-
pared with neurons from WT mice. Whether neurons with ab-
normal mitochondrial morphology observed in our study have
alterations in oxidative metabolism and mitochondrial
Ca2þhandling is not clear. We will address this question in our
future studies.
Taken together, our results suggest the lack of difference in
respiratory activities and Ca2þhandling in isolated brain mito-
chondria and cultured striatal neurons from R6/2 mice com-
pared with mitochondria and neurons from WT animals.
Discussion
In earlier studies, mitochondrial aberrations were proposed to
contribute to HD pathogenesis (for review see (33)). However,
despite significant effort, the role of mitochondrial dysfunction
A B
C D
Figure 3. Respiratory activity of brain synaptic mitochondria isolated from 6- to 8-week-old WT (thin traces) and R6/2 (thick traces) mice. In (A) and (B) are representa-
tive traces of mitochondrial O2 consumption for mitochondria at 37 C in incubation medium supplemented with pyruvate (3 mM) plus malate (1 mM) or succinate
(3 mM) plus glutamate (3 mM), respectively. Arrows indicate the addition of either synaptic mitochondria (Mtc), 200 mM ADP, or 60 mM 2,4-DNP. In (C) and (D) are statisti-
cal analyses of respiratory rates. Data are presented as mean6SEM from five separate experiments.
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in HD still remains controversial. In this study, we assessed the
effect of mHtt fragments on mitochondrial respiratory activity
and Ca2þhandling using both isolated brain mitochondria and
cultured striatal neurons from R6/2 mice. It remains not com-
pletely clear whether full-length mHtt or mHtt fragments medi-
ate HD pathogenesis. However, some studies suggest that mHtt
fragments might be more prone to aggregation and therefore
might be more toxic for neurons (8,9). In our previous study, we
demonstrated the lack of mitochondrial respiratory or
Ca2þhandling defects in mitochondria and cultured neurons
from YAC128 mice, which express human full-length mHtt (5,6).
Consequently, in this study, we hypothesized that fragments of
mHtt are more harmful to mitochondria than full-length mHtt.
If this would be the case, we may expect to detect mitochondrial
functional abnormalities induced by mHtt fragments. In this
study, we evaluated mitochondrial functions in the R6/2 mouse,
a mouse model of HD that expresses fragments of human mHtt
with 144 glutamines (12).
In our experiments, we used two model systems: isolated
brain mitochondria and primary cultured striatal neurons. It is
conceivable that there might be some difference in the results
produced with these two model systems. Mitochondria isolated
from adult brains may better reflect changes that take place in
HD over time. However, isolated mitochondria taken away from
their natural intracellular environment may lead to unwanted
artifacts (e.g. loss of association with mHtt) and, consequently,
to inaccurate interpretations. On the other hand, mitochondria
in young post-natal neurons are immersed within their natural
intracellular environment, but they might be too young for de-
veloping overt functional defects. The use of both, mitochondria
isolated from adult brains and mitochondria in post-natal neu-
rons, complement each other and help us to better assess possi-
ble effects of mHtt on the organelles.
Earlier studies reported mitochondrial respiratory dysfunc-
tion and a decreased ability of mitochondria to accumulate
Ca2þ in HD mouse models expressing full-length or fragments of
mHtt (34–37). On the other hand, studies from our group (5,6)
and from other investigators (23,38,39) suggest the lack of de-
fects in respiration and Ca2þuptake in mitochondria isolated
from brains of HD mice compared with mitochondria from
brains of WT animals. Consistent with these previous findings
in other mouse models of HD, our data presented here indicate
the lack of defects in respiration and Ca2þuptake in brain mito-
chondria isolated from R6/2 mice compared with brain mito-
chondria from WT mice. Similarly, in experiments with
cultured striatal neurons, our data demonstrate the lack of dif-
ference in cellular respiratory activity and Ca2þhandling be-
tween neurons from R6/2 and WT mice.
In this study, we used isolated brain mitochondria from
symptomatic 6- to 8-week-old R6/2 mice and age-matched WT
mice. The R6/2 mice used in our experiments displayed a clasp-
ing phenotype typical for HD animals (12). The presence of
Figure 4. Expression of nuclear encoded mitochondrial proteins in non-synaptic and synaptic mitochondria isolated from 8-week-old WT and R6/2 mice. In (A) and (C),
representative western blots of non-synaptic (A) or synaptic (C) mitochondria generated with antibodies against nuclear encoded mitochondrial proteins including
39 kDa subunit of Complex I, 30 and 70 kDa subunits of Complex II, aconitase 2, MnSOD, CyD, and a-subunit of ATP synthase (ATP synthase, a). VDAC1 was used as a
loading control. In B and D, the results of densitometry performed with NIH ImageJ 1.48v software. Data are mean6SEM from six separate experiments.
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clasping behavior assured us that if mitochondrial respiratory
abnormalities and aberrant Ca2þhandling by mitochondria
were involved in neuronal dysfunction leading to these behav-
ioral aberrations, then we should be able to detect such changes
in respiration, Ca2þhandling or both. The lack of difference be-
tween mitochondria from WT and R6/2 mice suggests that frag-
ments of mHtt do not impair mitochondrial respiratory and
Ca2þuptake activities. Accordingly, our data argue against de-
fects of mitochondrial functions as a contributing factor to HD-
related pathology in R6/2 mice.
Recently, Yano et al. (19) reported the lack of difference in
respiration of synaptic and non-synaptic mitochondria from R6/
2 mice compared with mitochondria from WT animals.
Nevertheless, the authors presented evidence for mHtt-induced
inhibition of protein import into mitochondria, and suggested
that such an inhibition might affect mitochondrial functions
later in the disease progression (19). According to the authors,
this inhibition of mitochondrial protein import might result in a
decreased expression of nuclear-encoded mitochondrial pro-
teins, but the authors did not provide experimental evidence
supporting this notion (19). Our data with mitochondria isolated
from R6/2 mice indicate the lack of difference in expression of
several randomly selected nuclear-encoded mitochondrial pro-
teins, suggesting the lack of defects in mitochondrial protein
import. This is consistent with the study by Orr et al. (2008) that
found that expression of nuclear encoded MnSOD as well as 30
and 70 kDa subunits of succinate dehydrogenase (Complex II) is
A
B
C
Figure 5. Ca2þuptake capacity of brain non-synaptic mitochondria isolated from
6-to 8-week-old WT (thin traces) and R6/2 (thick traces) mice. Ca2þuptake was
assessed in mitochondria incubated at 37 C in the standard incubation medium
supplemented with either 3 mM succinate plus 3 mM glutamate (A) or 3 mM py-
ruvate plus 1 mM malate (B). In all Ca2þuptake experiments, incubation medium
was additionally supplemented with 100 mM ADP and 1 mM oligomycin. In (C) is
statistical analysis of Ca2þuptake capacity of mitochondria from R6/2 and WT
mice. Data are mean6SEM, N¼5–6 separate experiments.
A
B
C
Figure 6. Ca2þuptake capacity of brain synaptic mitochondria isolated from 6- to
8-week-old WT (thin traces) and R6/2 (thick traces) mice. Ca2þuptake was as-
sessed in mitochondria incubated at 37 C in the standard incubation medium
supplemented with 3 mM succinate plus 3 mM glutamate either without (A) or
with (B) 0.1% BSA in the incubation medium. In all Ca2þuptake experiments, in-
cubation medium was additionally supplemented with 100 mM ADP and 1 mM
oligomycin. In (C) is statistical analysis of Ca2þuptake capacity of mitochondria
from R6/2 and WT mice. Data are mean6SEM from 5 separate experiments.
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similar in brain mitochondria isolated from 3- and 10-month-
old heterozygous knock-in 150Q/7Q mice as well as in 3-month-
old WT 7Q/7Q mice (40). Milakovic and Johnson (2005) also failed
to demonstrate a difference in expression of 30 and 70 kDa sub-
units of Complex II in mutant STHdhQ111/Q111 striatal cells com-
pared with WT STHdhQ7/Q7 cells (41).
Previously, Rosenstock et al. (42) reported a significant in-
crease in cytosolic Ca2þ induced by 1 mM glutamate in cortical
and striatal slices of 9 month-old R6/1 transgenic mice.
Following glutamate removal, FCCP-mediated mitochondrial
depolarization led to Ca2þ release from mitochondria and re-
sulted in an increase in cytosolic Ca2þ that was similar in slices
from both R6/1 and WT animals. This suggests the lack of de-
fects in mitochondrial Ca2þaccumulation in brain slices from
R6/1 mice.
The lack of defects in Ca2þuptake by non-synaptic mito-
chondria isolated from brains of R6/2 mice was also found by
David Nicholls’ group (21). Contrary to expectations, they found
a moderate but statistically significant increase in Ca2þuptake
capacity of mitochondria isolated from brains of R6/2 mice com-
pared with mitochondria from WT animals. Although we did
not find a statistically significant increase in Ca2þuptake capac-
ity in isolated brain mitochondria from R6/2 mice, we confirm
the lack of deterioration of mitochondrial Ca2þuptake capacity
in these mitochondria. The authors also found an increase in
Ca2þuptake capacity in non-synaptic mitochondria from
YAC128 mice, which express full-length mHtt, and the lack of
difference in mitochondria from knock-in Hdh150/þmice (21). In
addition, the authors did not find a significant difference in re-
spiratory activity of striatal neurons from Hdh150/þand WT
mice.
The reason for the increased Ca2þuptake capacity in mito-
chondria from HD mice is not clear but might be related to com-
pensatory changes in mitochondria and alterations in
susceptibility to induction of the permeability transition pore
(PTP), which determines mitochondrial Ca2þuptake capacity
(43). Interestingly, Choo et al. (44) reported a significantly in-
creased level of glutathione in cortical and striatal mitochondria
from R6/2 mice. The authors interpreted this finding as an indi-
cation of compensatory reaction to protect cells against an in-
crease in mitochondrial oxidative stress. An increase in
mitochondrial glutathione may also suggest increased resis-
tance to Ca2þ-induced damage that manifests in induction of
the PTP. Indeed, glutathione was found to be protective against
Ca2þ-induced PTP in liver (45), heart (46) and brain mitochondria
(47). Consequently, the same mechanism might contribute to
the lack of difference in Ca2þuptake capacity in our study of mi-
tochondria from R6/2 and WT mice.
Mitochondrial CyD is a component of the mitochondrial PTP
that sensitizes it to Ca2þ (48). Genetic ablation of CyD inhibits
PTP induction (49) and significantly increases Ca2þuptake ca-
pacity in brain mitochondria (50). Considering this, it was logical
to propose that if mitochondria from HD mice have increased
propensity to PTP induction and, concomitant decrease in
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Figure 7. OCR and ECAR of cultured striatal neurons from WT and R6/2 mice in ‘high’ and ‘low’ glucose medium conditions. Striatal neurons from post-natal day 1 R6/2
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Ca2þuptake capacity and if this defect in Ca2þhandling plays an
important role in HD pathology, then CyD deletion should pro-
tect mitochondria, increase Ca2þuptake capacity, and rescue be-
havioral deficits in R6/2 mice. Perry et al. reported elegant
experiments in which the authors crossed R6/2 with CyD-
knockout mice (CyD/) and evaluated mitochondrial
Ca2þuptake capacity in mitochondria from cerebral cortex of
crosses of CyD/ and R6/2 mice (51). The authors found a sig-
nificant increase in Ca2þuptake capacity in mitochondria from
R6/2:CyD/ mice but no indication of behavioral improvement
or alleviation of HD neuropathological features. From these re-
sults, the authors concluded that increasing neuronal mito-
chondrial Ca2þuptake capacity is not beneficial in the R6/2
model of HD. Unfortunately, in this study the authors failed to
compare Ca2þuptake capacity of brain mitochondria from R6/2
and WT mice. Based on our data and results from David
Nicholls’ group (21), Ca2þuptake capacities of isolated brain mi-
tochondria and mitochondria in cultured neurons from R6/2
mice are not decreased compared with Ca2þcapacity of mito-
chondria from WT animals. Consequently, alterations in
Ca2þuptake capacity most likely do not play a role in HD pathol-
ogy and one should not expect significant improvement in HD
pathology due to an increase in mitochondrial Ca2þuptake
capacity.
Overall, the data presented in this article, recent findings by
our group (5,6), and by other investigators (23,38,39) show no
significant differences in respiratory activity and Ca2þhandling
in mitochondria exposed to human full-length or truncated
mHtt. Consequently, based on our results and data from other
groups, the dearth of defects in bioenergetics and Ca2þhandling
makes their contribution to HD pathology unlikely. However,
this does not rule out the potential contribution of mitochon-
dria to HD pathogenesis. The neurotoxic effect of mHtt or its
fragments may be due to mechanisms that are not directly re-
lated to mitochondrial bioenergetics or Ca2þ transport but may
indirectly affect these functions. These mechanisms may in-
clude oxidative stress associated with elevated NAD(P)H oxidase
activity (52), alterations in cholesterol metabolism (53), aberrant
vesicular trafficking (27). In addition, numerous reports indicate
alterations in mitochondrial morphology and traffic in cell and
mouse models of HD (28,54,55). Our observations of alterations
in mitochondrial morphology in neurons from R6/2 mice made
with spinning-disk confocal and electron microscopy are con-
sistent with previously reported mitochondrial morphological
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Figure 8. Mitochondrial Ca2þaccumulation following transient glutamate-induced elevations in cytosolic Ca2þ in striatal neurons derived from WT and R6/2 mice. In A
and B, the averaged fluorescence signals (mean6SEM) from the representative experiments are shown. Cytosolic Ca2þwas followed by monitoring Fura-2FF F340/F380
fluorescence ratio at 37 C. In these experiments, striatal neurons (10–13 DIV) were exposed to 25 mM glutamate with 10 mM glycine for 2 min as indicated. Then, gluta-
mate and glycine were removed to let cytosolic Ca2þconcentration ([Ca2þ]c) recover. After [Ca
2þ]c reached near resting level (7 min after glutamate removal) neurons
were treated with 1 mM FCCP to depolarize mitochondria and release accumulated Ca2þ. To avoid ambiguity concerning possible Ca2þ influx from the outside of the
cell, external Ca2þwas removed simultaneously with glutamate and glycine. In addition, to prevent Ca2þextrusion from the cell by Naþ/Ca2þexchanger, the external
Naþwas replaced by equimolar NMDG as indicated. In (C) and (D), the areas under the curve (AUC) for the averaged fluorescence signals are shown. The AUC for gluta-
mate-induced increase in [Ca2þ]c (Glu AUC) was calculated for the 120-s period beginning with glutamate application. The AUC for FCCP-induced increase in [Ca
2þ]c
(FCCP Glu) was calculated for the 300-s period following FCCP application. Data are mean6SEM from five to six separate experiments with 20–25 individual neurons an-
alyzed in each experiment.
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abnormalities found in cells expressing mHtt (25–32). It is con-
ceivable that these alterations in mitochondrial morphology as
well as in non-mitochondrial mechanisms may play a signifi-
cant role in neuronal dysfunction and over time may lead to the
neuronal loss and behavioral deficits seen in HD.
Materials and Methods
Materials
Pyruvate, malate, succinate, glutamate, Ethylene glycol tetraacetic
acid (EGTA), ADP, oligomycin, rotenone, antimycin A, 2,4-DNP,
NMDG and carbonylcyanide-p-trifluoromethoxyphenylhydra-zone
(FCCP) were purchased from Sigma (St. Louis, MO, USA). BSA, free
from free fatty acids, was from MP Biomedicals (Irvine, CA, USA).
Animals
All procedures with animals were performed in accordance
with the Institutional Animal Care and Use Committee ap-
proved protocol. Mice were purchased from Jackson
Laboratories (Bar Harbor, ME) and breeding colonies were estab-
lished in Laboratory Animal Resource Center at Indiana
University School of Medicine, Indianapolis, IN. R6/2 mice and
their WT littermates were generated by crossing WT
CBAxC57Bl/6 F1 males with CBAxC57Bl/6 females that had ovary
transplants from R6/2 mice. All offspring were genotyped with a
PCR assay on tail DNA (12). The mice were housed under stan-
dard conditions with free access to water and food. In experi-
ments with isolated brain mitochondria, we used symptomatic
6- to 8-week-old R6/2 mice and their WT littermates (back-
ground: B6CBA). For preparing cultured neurons, we used post-
natal day 1 (PN1) mouse pups. R6/2 mice express the N-termi-
nus fragment of the human mHtt gene that encodes a patholog-
ically expanded polyglutamine stretch with 144 glutamines (12).
In our experiments, we used animals of both sexes. However, in
every individual experiment we only used animals of the same
sex. We did not find significant difference in the results ob-
tained with either sex and, therefore, the data were pooled to-
gether for statistical analysis.
Genotyping
All offspring were genotyped using a PCR assay on tail DNA (12).
Briefly, PCR of tail DNA was carried out following the protocol
provided by Jackson Laboratories with oligonucleotide primers
oIMR1594 (CCGCTCAGGTTCTGCTTTTA) and oIMR1596 (TTG
AAGGACTTGAGGGACTC) obtained from Invitrogen.
Figure 9. Representative 3D reconstructions of mitochondrial networks and electron micrographs of cultured striatal neurons from WT (A, C) and R6/2 (B, D) mice. In A
and B, the representative 3D maximal fluorescence intensity projection images of the mitochondrial network in live cultured striatal neurons (9 DIV) from WT and R6/2
mice, respectively (total number of neurons analyzed in these experiments—142 neurons from WT mice and 148 neurons from R6/2 mice). Cells were analyzed in a
blind manner. The scales are in mm. In C and D, representative electron micrographs of cultured striatal neurons (9 DIV) from WT and R6/2 mice, respectively.
Arrowheads point to small-size, normal-looking mitochondria; the arrow points to enlarged mitochondrion.
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Oligonucleotide primers oIMR7338 (CTAGGCCACAGAATTGAA
AGATCT) and oIMR7339 (GTAGGTGGAAA-TTCTAGCATCATCC)
(both from Invitrogen) were used as internal positive control.
The PCR reaction mixture consisted of 1 ml DNA template and
23 ml Platinum PCR SuperMix (Invitrogen) supplemented with
0.5 mM of each primer (Invitrogen), total volume 25 ml. Cycling
conditions were 2 min at 94C, 10 cycles for 20 s at 94C followed
by 15 s at 65C with 0.5C per cycle temperature decrease and
10 s at 68C. Then, 28 cycles for 15 s at 94 C followed by 15 s at
60 C and 10 s at 72 C, concluded by 1 min at 72C (Jackson
Laboratories, Bar Harbor, ME). Reaction products were analyzed
on 1.2% agarose gel run at 100 V for 60 min with Tris-acetate-
EDTA running buffer containing 1 GelRed Nucleic Acid Gel
Stain (Biotium, CA).
Isolation of non-synaptic and synaptic brain
mitochondria
Percoll gradient-purified brain non-synaptic and synaptic mito-
chondria from 6- to 8-week old R6/2 and WT mice were isolated
as we described previously (56,57). Previously, it was proposed
that BSA may displace mHtt from its binding sites on mitochon-
dria (15). For this reason, we omitted BSA from all solutions
used in our experiments with isolated mitochondria unless oth-
erwise mentioned.
Mitochondrial respiration
Mitochondrial respiration was assessed in a 0.4 ml, continu-
ously stirred, chamber containing the standard incubation me-
dium which was composed of 125 mM KCl, 0.5 mM MgCl2, 3 mM
KH2PO4, 10 mM Hepes, pH 7.4, 10 mM EGTA, supplemented either
with 3 mM pyruvate plus 1 mM malate or 3 mM succinate plus
3 mM glutamate. Experiments with succinate were supple-
mented with glutamate to prevent inhibition of succinate dehy-
drogenase by oxaloacetate (17,18). The chamber was
maintained at 37C and was equipped with a Clark-type oxygen
electrode and a tightly sealed lid. The slope of the oxygen elec-
trode trace corresponded to the respiratory rate.
Mitochondrial Ca2þuptake capacity
Mitochondrial Ca2þuptake was measured using a 0.3 ml cham-
ber at 37C under continuous stirring that was outfitted with a
miniature Ca2þ-selective electrode. Mitochondrial Ca2þuptake
was indicated by a decrease in the external Ca2þconcentration.
The standard incubation medium contained 125 mM KCl,
0.5 mM MgCl2, 3 mM KH2PO4, 10 mM Hepes, pH 7.4, 10 mM EGTA,
and was supplemented either with 3 mM pyruvate plus 1 mM
malate or 3 mM succinate plus 3 mM glutamate. Succinate was
used in combination with glutamate to prevent oxaloacetate in-
hibition of succinate dehydrogenase (17,18). The incubation me-
dium was further supplemented with 0.1 mM ADP and 1 mM
oligomycin as described previously (43). Ca2þwas delivered to
mitochondria as 10 mM CaCl2 pulses.
Cell culturing
Primary neuronal cultures were prepared from the striatum of
post-natal day 1 R6/2 pups and WT littermates as described pre-
viously (58), but without pooling cells from different pups to-
gether. For respirometry experiments, neurons were plated as
described for Ca2þ imaging experiments (58), but neurons were
seeded onto 24-well Seahorse plates. To inhibit proliferation of
non-neuronal cells, 35 mgml1 uridine plus 15 mgml1 5-
fluoro-20-deoxyuridine were added 24 h after plating. Neurons
were maintained in a 5% CO2 atmosphere at 37 C in Neurobasal
Medium with B27 supplement (Life Technologies).
Cell respirometry
A Seahorse XF24 flux analyzer (Seahorse Bioscience, Billerica,
MA, USA) was used to measure OCRs of cultured striatal neu-
rons (8 DIV) following the manufacturer’s instructions.
Neuronal cultures were seeded in the 24-well assay plates at 105
cells per well. Prior to the experiment, the growth medium was
exchanged for the standard bath solution supplemented with
10 mM glucose and 15 mM pyruvate or 2.5 mM glucose alone as
stated. The standard bath solution contained 139 mM NaCl,
3 mM KCl, 0.8 mM MgCl2, 1.8 mM CaCl2, 10 mM HEPES, pH 7.4,
37 C. For experiments with bath solution containing 2.5 mM
glucose, sucrose was added to maintain osmolarity similar to
that of the growth medium (280 mosm).
ATP measurements
ATP content was determined by using a luciferin/luciferase-based
ATP bioluminescent somatic cell assay kit (Sigma) and a GloMax
20/20 luminometer (Promega). Cultured striatal neurons (7 DIV)
were lysed on ice with 1 Releasing Reagent (Sigma), following
manufacturer’s instructions. ATP was measured following precipi-
tation of proteins by perchlorate (4%) and subsequent neutraliza-
tion of extracts by KOH according to manufacturer’s instructions.
Immunoblotting
Brain isolated mitochondria pretreated with Protease Inhibitor
Cocktail (Roche) were solubilized by incubation in NuPAGE LDS
sample buffer (Invitrogen, Carlsbad, CA, USA) supplemented
with a reducing agent at 70C for 15 min. Bis-Tris Mops gels
(12%, Invitrogen) was used for electrophoresis (20 mg protein per
lane). After electrophoresis, proteins were transferred to
Hybond-ECL nitrocellulose membrane (Amersham Biosciences).
Blots were incubated for 1 h at room temperature in blocking so-
lution of 5% BSA, phosphate-buffered saline, pH 7.2, and 0.15%
Triton X-100. Then, blots were incubated with one of the follow-
ing primary antibodies: mouse monoclonal anti-Complex I
39 kDa subunit (Invitrogen, 1:1000), mouse monoclonal anti-
Complex II 30 kDa subunit (Invitrogen, 1:1000), mouse monoclo-
nal anti-Complex II 70 kDa subunit (Invitrogen, 1:1000), mouse
monoclonal anti-aconitase 2 (Abcam, 1:1000), rabbit polyclonal
anti-manganese superoxide dismutase (MnSOD, Millipore,
1:2000), mouse monoclonal anti-ATP synthase a subunit
(Abcam, 1:1000), mouse monoclonal anti-aconitase 2 (Abcam,
1:1000), mouse monoclonal anti-CyD antibody (Calbiochem,
1:500), rabbit polyclonal anti-VDAC1 (Calbiochem, 1:1000). Blots
were incubated with goat anti-mouse or goat anti-rabbit IgG
(1:20 000) coupled with horseradish peroxidase (Jackson
ImmunoResearch Laboratories, West Grove, PA, USA) and devel-
oped with Supersignal West Pico chemiluminescent reagents
(Pierce, Rockford, IL, USA). Molecular mass markers See Blue
Plus 2 Standards (5 ml) and HiMark Pre-stained High Molecular
Weight Protein Standards (10 ml) (Invitrogen) were used to deter-
mine molecular masses of the bands. NIH ImageJ 1.48v software
(http://rsb.info.nih.gov//ij, last accessed: April 1, 2016) was used
to quantify band densities.
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Calcium imaging
Cytosolic Ca2þwas assessed in striatal neurons (10–12 days in vi-
tro, DIV) by loading neurons at 37 C with 2.6 mM Fura-2FF-AM
(Molecular Probes, Eugene, OR) in a bath solution containing
139 mM NaCl, 3 mM KCl, 0.8 mM MgCl2, 1.8 mM CaCl2, 10 mM
NaHEPES, pH 7.4 and 5 mM glucose. Osmolarity of the bath solu-
tions was measured with an Osmette II osmometer (Precision
Systems Inc., Natick, MA) to ensure that it was close to the os-
molarity of the growth medium (280 mosm). A Nikon Eclipse
TE2000-U inverted microscope using a Nikon CFI Plan Fluor 20
0.45 NA objective and a back-thinned EM-CCD camera,
Hamamatsu C9100-12 (Hamamatsu Photonic Systems,
Bridgewater, NJ) controlled by Simple PCI software 6.1 (Compix
Inc., Sewickley, PA) was used to take fluorescent images. A
Lambda-LS system (Sutter Instruments, Novato, CA) was used
to deliver excitation light. A Lambda 10-2 optical filter changer
(Sutter Instruments, Novato, CA) was used to control excitation
filters (3406 5 and 38067 nm). Fluorescence was recorded
through a 505 nm dichoroic mirror at 5356 25 nm. Images were
taken every 15 s for the duration of the experiment. The expo-
sure time was chosen that provided satisfactory image quality
but minimal exposure. The ratio of F340/F380, calculated follow-
ing background subtraction in both channels, was used to moni-
tor changes in cytosolic Ca2þconcentration ([Ca2þ]c). After 90 s
of baseline fluorescence recording in standard bath solution,
glutamate (25 mM) plus glycine (10 mM) was applied to the neuro-
nal culture. At the end of the experiment, the glutamate-
containing solution was replaced with a glutamate-, Ca2þ- and
Naþ-free solution. The Naþwas replaced by equimolar NMDG.
Then 1 mM FCCP was applied to the neurons, causing neuronal
mitochondria to depolarize and leading to release of accumu-
lated mitochondrial Ca2þ into the cytosol. The Grynkiewicz
method (59) was used for calculation of [Ca2þ]c from Fura-2FF
signals, using an assumed Kd for Fura-2FF of 5.5mM.
Fluorescence background was subtracted in every experiment.
As has been suggested previously (60,61), it should be noted
that the Ca2þbinding and spectroscopic properties of fluores-
cent dyes can differ depending on the intracellular environ-
ment. Therefore calculations of [Ca2þ]c should be considered
estimates.
Neuronal transfection
To visualize mitochondria within live cells, cultured striatal
neurons were transfected in suspension during plating using an
electroporator BTX 630 ECM (Harvard Apparatus, Holliston, MA)
with a plasmid encoding mitochondrially-targeted enhanced
yellow fluorescent protein (mito-eYFP, generously provided by
Dr. Roger Tsien, UCSD) as we described before for hippocampal
neurons (62). This procedure usually provided a 10–15% trans-
fection rate in primary cultures of rat hippocampal neurons
compared with <1% efficacy with commercial cationic lipid li-
posomes. The transfected neurons were imaged 8–10 days after
transfection.
Live-cell laser spinning-disk confocal microscopy
Mitochondrial morphology in live striatal neurons was analyzed
as described previously (62). Briefly, serial images of neuronal
mitochondria, visualized with mito-eYFP, were collected using
spinning-disk confocal microscopy. A Nikon Eclipse TE2000-U
microscope equipped with a Yokogawa spinning-disk confocal
unit CSU-10, a back-thinned EM-CCD camera Andor
iXonEMþDU-897 (Andor Technology, South Windsor, CT), and a
motorized stage Prior H-117 (Prior Scientific, Rockland, MA) was
employed. This setup was controlled by Andor iQ 1.4 software
(Andor Technology, South Windsor, CT). To image mitochon-
dria, neurons were exposed to excitation light at 488 nm using
an air-cooled Kr/Ar laser T643-RYB-A02 (Melles Griot, Carlsbad,
CA). The laser power was set to the minimum (<5%) to prevent
photobleaching. Fluorescence was collected through a 505 nm
dichroic mirror and a 535625 nm emission filter using a Nikon
CFI Plan Apo 100 1.4 NA objective. Serial images (z-stacks)
were collected using the piezoelectric positioning device PIFOC
P-721 (Physik Instrumente, Auburn, MA) with a z-step of 0.1 mm.
The spatial resolution of the Andor iXonEMþDU-897 camera
was increased by installing a 2 extender lens in front of the
camera. Three-dimensional blind deconvolution of z-stacks and
3D rendering were performed using AutoDeblur Gold CF 1.4.1
software (MediaCybernetics, Silver Spring, MD). Three-
dimensional maximal projection reconstructions of the mito-
chondrial network in live neurons were performed using Imaris
6.4.0 (Bitplane Inc., St. Paul, MN).
Transmission electron microscopy
Electron microscopy of cultured striatal neurons was performed
similarly to the procedure described earlier (63). Briefly, neurons
were fixed in 2% glutaraldehyde in the standard bath solution at
room temperature for 15 min. The cells were pelleted by centri-
fugation and the supernatant was discarded. The pellet was lay-
ered with a fresh solution of 2% glutaraldehyde in the standard
bath solution and left overnight at 4 C. The samples were post-
fixed in 1% osmium tetroxide for 1 h and dehydrated through a
series of graded ethyl alcohols before embedding in the resin
Embed 812 (Electron Microscopy Sciences, Fort Washington,
PA). Thick sections were cut on an Ultracut UCT microtome
(Leica, Bannockburn, IL), and then thin sections were cut using
a diamond knife (Diatome, Electron Microscopy Sciences) at 70–
90 nm and stained with uranyl acetate and lead citrate. Digital
electron micrographs were taken using a Tecnai G12 BioTwin
electron microscope (FEI, Hillsboro, OR) equipped with an
AMT2.6 2.6K digital CCD camera. Mitochondrial morphology
in striatal neurons was analyzed in a blind manner.
Statistics
Power analysis was performed using G*Force software version
3.1.9.2 (by Franz Faul, Universitat Kiel, Germany) to establish
the sample size necessary to detect a 20% difference between
mitochondria from WT and YAC128 mice. Based on this power
analysis, the number of experiments that gives an 80% likeli-
hood of detecting 20% difference between two means at the sig-
nificance level of a¼ 0.05 is 5–6. Data are shown as mean6SEM
of indicated number of separate experiments. Statistical analy-
sis of the experimental results consisted of unpaired t-test or
one-way ANOVA followed by Bonferroni’s post hoc test if appli-
cable (GraphPad Prism 4.0, GraphPad Software Inc., San Diego,
CA, USA).
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